Acute Dystonia Associated with Paliperidone Overdose

Psychosomatics

Volumn 52, Issue 3, 2011, Pages 291-294

  Lapid, Maria I ^a   Cunningham, Julie L ^a   Hugo, Zachary ^a   Kung, Simon ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; BENZODIAZEPINE; DIPHENHYDRAMINE; LORAZEPAM; PALIPERIDONE; SERTRALINE; 9 HYDROXY RISPERIDONE; 9-HYDROXY-RISPERIDONE; ISOXAZOLE DERIVATIVE; NEUROLEPTIC AGENT; PYRIMIDINE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DRUG OVERDOSE; DRUG URINE LEVEL; DYSTONIA; HUMAN; MALE; MUSCLE SPASM; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; URINALYSIS; BIPOLAR DISORDER; CHEMICALLY INDUCED DISORDER; INTOXICATION;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DYSTONIA; HUMANS; ISOXAZOLES; MALE; OVERDOSE; PYRIMIDINES; YOUNG ADULT;

EID: 80052890021     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2010.12.004     Document Type: Article

References (29)

1. Lasser K.E., Allen P.D., Woolhandler S.J., et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002, 287:2215-2220. [see comment].
2. Invega (Paliperidone®) extended-release tablets 2009, Ortho-McNeil-Janssen Pharmaceuticals Inc, Titusville, NJ, [product insert].
3. Davidson M., Emsley R., Kramer M., et al. Efficacy, safety, and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study. Schizophr Res 2007, 93:117-130. [erratum appears in Schizophr Res 2007; 96:273-274].
4. Kane J., Canas F., Kramer M., et al. Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial. Schizophr Res 2007, 90:147-161.
5. Product information risperidone (Risperdal®) 2009, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Titusville, NJ, [product insert].
6. Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Text Revision (DSM-IV-TR), American Psychiatric Press, Washington, DC. 4th ed.
7. Casey D.E. Narcoleptics-induced acute dystonia. DSM-IV Sourcebook 1994, Vol I. American Psychiatric Publishing, Inc., Washington, DC, American Psychiatric Association Task Force on DSM-IV, Eds. T.A. Widiger (Ed.).
8. Brody A.L. Acute dystonia-induced by rapid increase in risperidone dosage. J Clin Psychopharmacol 1996, 16:461-462.
9. Kropp S., Hauser U., Ziegenbein M. Quetiapine-associated acute dystonia. Ann Pharmacother 2004, 38:719-720.
10. Landry P., Cournoyer J. Acute dystonia with olanzapine. J Clin Psychiatry 1998, 59:384.
11. Rosenfield P.J., Girgis R.R., Gil R. High-dose ziprasidone-induced acute dystonia. Prog Neuro-Psychopharmacol Biol Psychiatry 2007, 31:546-547.
12. Varkula M., Dale R. Acute dystonic reaction after initiating aripiprazole monotherapy in a 20-year-old man. J Clin Psychopharmacol 2008, 28:245-247.
13. Iloperidone (Fanapt™) tablets 2009, Vanda Pharmaceuticals Inc., Rockville, MD, [product insert].
14. Asenapine (Saphris®) sublingual tablets 2009, Schering-Plough Corp., Kenilworth, NJ, [product insert].
15. Burns M.J. The pharmacology and toxicology of atypical antipsychotic agents. J Toxicol Clin Toxicol 2001, 39:1-14.
16. van Beijsterveldt L.E., Geerts R.J., Leysen J.E., et al. Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat. Psychopharmacology 1994, 114:53-62.
17. Schotte A., Janssen P.F., Gommeren W., et al. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology 1996, 124:57-73.
18. Conley R., Gupta S.K., Sathyan G. Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form. Curr Med Res Opinion 2006, 22:1879-1892.
19. Invega® Sustenna™ 2009, Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, Titusville, NJ, [product insert].
20. Acri A.A., Henretig F.M. Effects of risperidone in overdose. Am J Emergency Med 1998, 16:498-501.
21. Lee H.S., Tan C.H., Au L.S., et al. Serum and urine risperidone concentrations in an acute overdose. J Clin Psychopharmacol 1997, 17:325-326.
22. Nishikage H., Nakanishi T., Takamitsu Y., et al. Sequential changes in the plasma concentration of risperidone following intentional overdose. Clin Neuropharmacol 2002, 25:307-309.
23. Detweiler M.B., Harpold G.J. Bupropion-induced acute dystonia. Ann Pharmacother 2002, 36:251-254.
24. Milton J.C., Abdulla A. Prolonged oro-facial dystonia in a 58-year-old female following therapy with bupropion and St. John's Wort. Br J Clin Pharmacol 2007, 64:717-718.
25. Lewis C.F., DeQuardo J.R., Tandon R. Dystonia associated with trazodone and sertraline. J Clin Psychopharmacol 1997, 17:64-65.
26. Stanislav S.W., Childs N.L. Dystonia associated with sertraline. J Clin Psychopharmacol 1999, 19:98-100.
27. Walker L. Sertraline-induced akathisia and dystonia misinterpreted as a panic attack. Psychiat Services 2002, 53:1477-1478.
28. Demetropoulos S., Schauben J.L. Acute dystonic reactions from "street Valium.". J Emerg Med 1987, 5:293-297.
29. Hooker E.A., Danzl D.F. Acute dystonic reaction due to diazepam. J Emerg Med 1988, 6:491-493. [see comment].